ABT Molecular Imaging, a Knoxville, Tenn.-based medical imaging company developing a production platform to generate unit doses of molecular imaging drugs, has secured a $9m Series A financing.
The round was led by venture capital firm Intersouth Partners, with company founders participating.
The funds will be used to complete product development and execute an initial sales strategy.
Commenitng on the financing, Ronald Nutt, Ph.D., Founder and Chairman of ABT Molecular Imaging, said: “This investment in ABT is a tremendous endorsement of the market opportunity our technology provides.
“Having grown the company over the last three years, this infusion of capital will allow us to accelerate that growth, enabling our ability to bring this innovative technology to market”.